Patient Travel and Reimbursements for AL Amyloidosis Study
This three-year rare disease study was being conducted at 75 study sites throughout the United States, Canada, Europe, and Australia. The study required a 13-month commitment from patients, and had a rigorous visit calendar for the first 3 months of treatment, thus the sponsor was seeking assistance with patient travel and coordination.
Please fill out the form on the right to review the case study.
ClinEdge (en-US)Every Stage of Every Study. Creating innovative solutions that connect and empower the clinical trial ecosystemhttps://clin-edge.comHomehttps://clin-edge.comCaseshttps://clin-edge.com/caseshttps://clin-edge.com/cases/patient-travel-and-reimbursements-for-al-amyloidosis-study